PIPECURONIUM: 20 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
20
Total FAERS Reports
2 (10.0%)
Deaths Reported
2
Hospitalizations
20
As Primary/Secondary Suspect
Jun 26, 1990
FDA Approved
Discontinued
Status
Active Ingredient: PIPECURONIUM BROMIDE · FDA Application: 019638 ·
First Report: 201404 · Latest Report: 20190508
What Are the Most Common PIPECURONIUM Side Effects?
#1 Most Reported
Foetal exposure during pregnancy
10 reports (50.0%)
#2 Most Reported
Syndactyly
8 reports (40.0%)
#3 Most Reported
Dysmorphism
8 reports (40.0%)
All PIPECURONIUM Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Foetal exposure during pregnancy | 10 | 50.0% | 0 | 0 |
| Adrenal insufficiency | 8 | 40.0% | 0 | 0 |
| Congenital clavicular agenesis | 8 | 40.0% | 0 | 0 |
| Dysmorphism | 8 | 40.0% | 0 | 0 |
| Syndactyly | 8 | 40.0% | 0 | 0 |
| Hypoglycaemia | 7 | 35.0% | 0 | 0 |
| Anaemia | 6 | 30.0% | 1 | 0 |
| Cardiac failure | 6 | 30.0% | 1 | 0 |
| Sinus tachycardia | 6 | 30.0% | 1 | 0 |
| Alpha haemolytic streptococcal infection | 5 | 25.0% | 0 | 0 |
| Cardiac valve abscess | 5 | 25.0% | 0 | 0 |
| Cardiac valve vegetation | 5 | 25.0% | 0 | 0 |
| Dyspnoea | 5 | 25.0% | 0 | 0 |
| Ejection fraction decreased | 5 | 25.0% | 0 | 0 |
| Hyperthyroidism | 5 | 25.0% | 0 | 0 |
| Hypokinesia | 5 | 25.0% | 0 | 0 |
| Thyroid cyst | 5 | 25.0% | 0 | 0 |
Who Reports PIPECURONIUM Side Effects? Age & Gender Data
Gender: 100.0% female, 0.0% male. Average age: 25.0 years. Most reports from: HU. View detailed demographics →
Is PIPECURONIUM Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2014 | 2 | 1 | 1 |
| 2019 | 1 | 1 | 0 |
What Is PIPECURONIUM Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 7 |
Official FDA Label for PIPECURONIUM
Official prescribing information from the FDA-approved drug label.